» Articles » PMID: 27433880

False-negative Rate Cannot Be Reduced by Lowering the Haemoglobin Concentration Cut-off in Colorectal Cancer Screening Using Faecal Immunochemical Test

Overview
Specialty Oncology
Date 2016 Jul 20
PMID 27433880
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to analyse false-negative (FN) results of the faecal immunochemical test (FIT) and its determinants in a colorectal cancer screening programme in Catalonia. We carried out a cross-sectional study among 218 screenees with a negative FIT result who agreed to undergo a colonoscopy. A false-negative result was defined as the detection, at colonoscopy, of intermediate/high-risk polyps or colorectal cancer in a patient with a previous negative FIT (<20 µgHb/g). Multivariate logistic regression models were constructed to identify sociodemographic (sex, age) and screening variables (quantitative faecal haemoglobin, colonoscopy findings) related to FN results. Adjusted odds ratios and their 95% confidence intervals were estimated. There were 15.6% FN FIT results. Faecal haemoglobin was undetected in 45.5% of these results and was below 4 µgHb/g in 94.0% of the individuals with a FN result. About 60% of the lesions were located in the proximal colon, whereas the expected percentage was 30%. Decreasing the positivity threshold of FIT does not increase the detection rate of advanced neoplasia, but may increase the costs and potential adverse effects.

Citing Articles

The Development and Optimisation of a Urinary Volatile Organic Compound Analytical Platform Using Gas Sensor Arrays for the Detection of Colorectal Cancer.

Arasaradnam R, Krishnamoorthy A, Hull M, Wheatstone P, Kvasnik F, Persaud K Sensors (Basel). 2025; 25(3).

PMID: 39943238 PMC: 11820771. DOI: 10.3390/s25030599.


Quantification of mitochondrial cfDNA reveals new perspectives for early diagnosis of colorectal cancer.

Linke C, Hunger R, Reinwald M, Deckert M, Mantke R BMC Cancer. 2023; 23(1):291.

PMID: 36997875 PMC: 10064655. DOI: 10.1186/s12885-023-10748-y.


Prediction of the severity of colorectal lesion by fecal hemoglobin concentration observed during previous test in the French screening program.

Balamou C, Koivogui A, Rodrigue C, Clerc A, Piccotti C, Deloraine A World J Gastroenterol. 2021; 27(31):5272-5287.

PMID: 34497450 PMC: 8384754. DOI: 10.3748/wjg.v27.i31.5272.


Prediction of advanced colonic neoplasm in symptomatic patients: a scoring system to prioritize colonoscopy (COLONOFIT study).

Fernandez-Banares F, Cleries R, Boadas J, Ribes J, Oliva J, Alsius A BMC Cancer. 2019; 19(1):734.

PMID: 31345180 PMC: 6659265. DOI: 10.1186/s12885-019-5926-4.


Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.

de Klerk C, Vendrig L, Bossuyt P, Dekker E Am J Gastroenterol. 2018; 113(12):1778-1787.

PMID: 30158713 PMC: 6768609. DOI: 10.1038/s41395-018-0212-7.